agilon health (NYSE:AGL) Coverage Initiated at Citigroup

Citigroup began coverage on shares of agilon health (NYSE:AGLFree Report) in a research note published on Monday morning, Marketbeat Ratings reports. The brokerage issued a neutral rating and a $6.00 target price on the stock.

AGL has been the topic of a number of other research reports. Evercore ISI reduced their price objective on agilon health from $7.00 to $6.00 and set an in-line rating on the stock in a research note on Wednesday, February 28th. Royal Bank of Canada reduced their price objective on agilon health from $11.00 to $8.00 and set an outperform rating on the stock in a research note on Wednesday, February 28th. Wolfe Research downgraded agilon health from an outperform rating to a peer perform rating in a research note on Monday, January 8th. Stifel Nicolaus reduced their price objective on agilon health from $10.00 to $9.00 and set a hold rating on the stock in a research note on Thursday, February 22nd. Finally, Barclays began coverage on agilon health in a research note on Wednesday, March 6th. They issued an underweight rating and a $5.00 price objective on the stock. One investment analyst has rated the stock with a sell rating, twelve have assigned a hold rating and four have given a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of Hold and a consensus target price of $9.46.

Check Out Our Latest Analysis on agilon health

agilon health Stock Down 5.4 %

AGL stock opened at $5.17 on Monday. The business’s 50-day moving average price is $5.71 and its 200-day moving average price is $9.75. The stock has a market cap of $2.12 billion, a P/E ratio of -7.95 and a beta of 0.49. agilon health has a twelve month low of $4.41 and a twelve month high of $26.75. The company has a quick ratio of 1.51, a current ratio of 1.51 and a debt-to-equity ratio of 0.05.

agilon health (NYSE:AGLGet Free Report) last issued its earnings results on Tuesday, February 27th. The company reported ($0.41) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.28) by ($0.13). The business had revenue of $1.06 billion for the quarter, compared to the consensus estimate of $1.02 billion. agilon health had a negative net margin of 5.76% and a negative return on equity of 21.74%. The firm’s revenue for the quarter was up 71.8% compared to the same quarter last year. During the same period last year, the business posted ($0.14) EPS. On average, equities research analysts forecast that agilon health will post -0.35 EPS for the current year.

Hedge Funds Weigh In On agilon health

Large investors have recently bought and sold shares of the business. CWM LLC boosted its holdings in agilon health by 83.7% during the 3rd quarter. CWM LLC now owns 1,585 shares of the company’s stock valued at $28,000 after acquiring an additional 722 shares during the period. Signaturefd LLC boosted its holdings in agilon health by 73.7% during the 3rd quarter. Signaturefd LLC now owns 1,673 shares of the company’s stock valued at $30,000 after acquiring an additional 710 shares during the period. Ronald Blue Trust Inc. purchased a new position in agilon health during the 3rd quarter valued at $38,000. Quest Partners LLC purchased a new stake in shares of agilon health in the 4th quarter worth $45,000. Finally, Neo Ivy Capital Management purchased a new stake in shares of agilon health in the 4th quarter worth $47,000.

agilon health Company Profile

(Get Free Report)

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.

See Also

Analyst Recommendations for agilon health (NYSE:AGL)

Receive News & Ratings for agilon health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for agilon health and related companies with MarketBeat.com's FREE daily email newsletter.